Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,44117,460 of 20,252 grants

Completed SBIR-STTR RPGS
High-throughput Label-free Biosensor Platform for Rapid Detection of Antigen-specific T Cells with Single Cell Resolution
NATIONAL CANCER INSTITUTE Weddell Technologies Llc United States 2021 – 2024

Project Summary / Abstract Immunotherapy has become a rapidly growing segment of cancer treatment with impressive success across a spectrum of malignancies including melanoma, colo...

$4M
USD
Completed SBIR-STTR RPGS
PRANAYAMA BASED GROUP VIDEO APP FOR CANCER SURVIVORSHIP. Phase I. Breast Cancer Pilot
NATIONAL CANCER INSTITUTE Pranascience Institute Llc United States 2021 – 2023

PROJECT SUMMARY Cancer remains the second leading cause of deaths in the U.S.Encouragingly, recent improvements in early diagnosis and treatment has led to significant increases in...

$3.89M
USD
Completed OTHER RESEARCH-RELATED
The immunosuppressive function of secretory IgM in tumor-bearing mice
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2021 – 2024

Project Summary/Abstract Myeloid-derived suppressor cells (MDSCs) exert potent immunosuppressive functions within tumor microenvironments to promote tumor growth.It is critical to...

$1.94M
USD
Completed OTHER RESEARCH-RELATED
Investigating the biology and therapeutic vulnerabilities of ER+ metastatic breast cancer with activating HER2 mutations
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

Project Summary/Abstract The candidate, Ms.Utthara Nayar, PhD, is a translational cancer biologist, and currently a Research Fellow in Medicine at Dana-Farber Cancer Institute, Har...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2023

The proposed project is in the field of thoracic oncology.Lung cancer patients that get treated with radiotherapy and immunotherapy are at risk of developing serious lung side-effe...

$3.47M
USD
Completed TRAINING, INDIVIDUAL
Targeted Chemical-Genetic Screen Platform for Identifying Novel AML Therapeutics
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2024

PROJECT ABSTRACT Over 93% of cancer patients do not receive therapeutic benefit from oncology precision medicine.This can be partly attributed to 1) not understanding the genetic t...

$485.9K
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$3.95M
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$1.02M
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$145.5K
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$3.48M
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$1.31M
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$281.1K
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2024

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$3.83M
USD
Completed NON-SBIR/STTR RPGS
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2025

Our project proposes an academic-industrial partnership to translate a novel lung function imaging modality into clinical care for lung cancer patients receiving radiation therapy....

$1.19M
USD
Completed TRAINING, INDIVIDUAL
EpoxySEAKER and onSEAKER: CAR T-Cell Systems for Targeted Local Biosynthesis of Therapeutic Warheads
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

EPOXYSEAKER AND ONSEAKER: CAR T-CELL SYSTEMS FOR TARGETED LOCAL BIOSYNTHESIS OF THERAPEUTIC WARHEADS Our labs have developed novel SEAKER (Synthetic Enzyme-Armed KillER) CAR T-cell...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
EpoxySEAKER and onSEAKER: CAR T-Cell Systems for Targeted Local Biosynthesis of Therapeutic Warheads
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

EPOXYSEAKER AND ONSEAKER: CAR T-CELL SYSTEMS FOR TARGETED LOCAL BIOSYNTHESIS OF THERAPEUTIC WARHEADS Our labs have developed novel SEAKER (Synthetic Enzyme-Armed KillER) CAR T-cell...

$467.5K
USD
Completed TRAINING, INDIVIDUAL
EpoxySEAKER and onSEAKER: CAR T-Cell Systems for Targeted Local Biosynthesis of Therapeutic Warheads
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2023

EPOXYSEAKER AND ONSEAKER: CAR T-CELL SYSTEMS FOR TARGETED LOCAL BIOSYNTHESIS OF THERAPEUTIC WARHEADS Our labs have developed novel SEAKER (Synthetic Enzyme-Armed KillER) CAR T-cell...

$270K
USD
Completed NON-SBIR/STTR RPGS
Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2023

PROJECT SUMMARY Metastatic prostate cancer (mPCa) is incurable and responsible for the majority of PCa associated mortality.Therefore, there is a critical need to identify intercep...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2023

PROJECT SUMMARY Metastatic prostate cancer (mPCa) is incurable and responsible for the majority of PCa associated mortality. Therefore, there is a critical need to identify interce...

$1.96M
USD
Completed NON SBIR/STTR CONTRACTS
PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2023

Lung cancer is the leading cause of cancer mortality worldwide.KRAS is the most common oncogene in lung adenocarcinoma patients while EGFR mutations occur in 47.9% of Asia-Pacific...

$9.12M
USD